Stephanie N Giamberardino
Overview
Explore the profile of Stephanie N Giamberardino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newman B, Danoff J, Lynch M, Giamberardino S, Gregory S, Connelly J, et al.
Aging Cell
. 2024 Nov;
:e14426.
PMID: 39605173
Epigenetic clocks provide powerful tools for estimating health and lifespan but their ability to predict brain degeneration and neuronal damage during the aging process is unknown. In this study, we...
2.
Karady J, McGarrah R, Nguyen M, Giamberardino S, Meyersohn N, Lu M, et al.
Am J Prev Cardiol
. 2024 May;
18:100680.
PMID: 38764778
Objectives: To determine the relationship between lipoprotein particle size/number with hepatic steatosis (HS), given its association with traditional lipoproteins and coronary atherosclerosis. Methods: Individuals with available CT data and blood...
3.
Graves A, Danoff J, Kim M, Brindley S, Skyberg A, Giamberardino S, et al.
Sci Rep
. 2024 Apr;
14(1):9646.
PMID: 38671048
While chronological age is a strong predictor for health-related risk factors, it is an incomplete metric that fails to fully characterize the unique aging process of individuals with different genetic...
4.
Zhao E, Giamberardino S, Pagidipati N, Voora D, Ginsburg G, Hoffmann U, et al.
J Am Heart Assoc
. 2023 May;
12(11):e028410.
PMID: 37218594
Background The interplay between branched-chain amino acid (BCAA) metabolism, an important pathway in adiposity and cardiometabolic disease, and visceral adipose depots such as hepatic steatosis (HS) and epicardial adipose tissue...
5.
Siecinski S, Giamberardino S, Spanos M, Hauser A, Gibson J, Chandrasekhar T, et al.
Autism Res
. 2023 Jan;
16(3):502-523.
PMID: 36609850
Oxytocin (OT), the brain's most abundant neuropeptide, plays an important role in social salience and motivation. Clinical trials of the efficacy of OT in autism spectrum disorder (ASD) have reported...
6.
McGarrah R, Ferencik M, Giamberardino S, Hoffmann U, Foldyna B, Karady J, et al.
J Am Heart Assoc
. 2022 Dec;
12(1):e026662.
PMID: 36565187
BACKGROUND More than half of major adverse cardiovascular events (MACE) occur in the absence of obstructive coronary artery disease and are often attributed to the rupture of high-risk coronary atherosclerotic...
7.
Lerman J, Giamberardino S, Hernandez A, Felker G, Shah S, McGarrah R
Sci Rep
. 2022 Jun;
12(1):9183.
PMID: 35654972
Heart failure with reduced ejection fraction (HFrEF) is increasingly treated with medications for type 2 diabetes mellitus (T2DM). Whether metabolic derangements in HFrEF and T2DM are associated with differential outcomes...
8.
Allen J, Danoff J, Costello M, Loeb E, Davis A, Hunt G, et al.
Dev Psychopathol
. 2022 Apr;
35(2):912-925.
PMID: 35379374
This study examined struggles to establish autonomy and relatedness with peers in adolescence and early adulthood as predictors of advanced epigenetic aging assessed at age 30. Participants ( = 154;...
9.
Allen J, Danoff J, Costello M, Hunt G, Hellwig A, Krol K, et al.
Drug Alcohol Depend
. 2022 Mar;
233:109363.
PMID: 35231715
Aims: This study was designed to assess links between lifetime levels of marijuana use and accelerated epigenetic aging. Design: Prospective longitudinal study, following participants annually from age 13 to age...
10.
SoRelle E, Dai J, Bonglack E, Heckenberg E, Zhou J, Giamberardino S, et al.
Elife
. 2021 Nov;
10.
PMID: 34762045
No abstract available.